Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...
Hepatitis B is not a particularly common condition in the United States. Data from 2021 estimates that between 880,000 and 1.89 million individuals are living with chronic hepatitis B in the U.S. This ...
More than 75% of chronic hepatitis B diagnoses in the United States occur late — within 2 years before or after the onset of a liver complication — highlighting the need for improved screening to ...
In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. Researchers have discovered that cells blood vessels in the liver start a ...
In 1991, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended hepatitis B vaccination at birth for all ...
Chronic hepatitis B (CHB) poses a major global health burden, with China particularly affected. Effective antiviral therapy is crucial to prevent disease progression, but responses may vary by ...
Hepatitis A and hepatitis B can be prevented with vaccines. CDC recommends all eligible gay and bisexual men get vaccinated ...
Officials in Guinea-Bissau have stopped a controversial, US government-funded clinical trial examining the side effects of the hepatitis B vaccine, according to media reports.
Hepatitis B vaccinations for Oregon newborns fell to 82% in 2024 from 86% in 2022, while birth parent screening also having ...
Children and infants can contract hepatitis B. Some children may recover without treatment and have no long-term effects, but for others it can turn into a lifelong infection. Hepatitis B is a liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results